aluates Reports

$ 0.0

Automative

Global Bacterial Vaginosis Therapeutics Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-5L14689

Global Bacterial Vaginosis Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Bacterial Vaginosis Therapeutics Market Research Report 2025

Code: QYRE-Auto-5L14689

Report

August 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Merck

Novartis

Lupin Pharmaceuticals

Symbiomix Therapeutics

Mission Pharmacal Company

Bayer

Sanofi

Starpharma Holdings

Alfa Wassermann

AMVAC

Evofem Inc

Osel

Bacterial Vaginosis Therapeutics Market Size

The global market for Bacterial Vaginosis Therapeutics was valued at US$ 1108 million in the year 2024 and is projected to reach a revised size of US$ 1802 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Bacterial Vaginosis Therapeutics Market

Bacterial vaginosis is an infection characterised by overgrowth of anaerobic bacteria in the vagina with an accompanying loss of lactobacilli.

North American market for Bacterial Vaginosis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bacterial Vaginosis Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Bacterial Vaginosis Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Bacterial Vaginosis Therapeutics include Pfizer, Merck, Novartis, Lupin Pharmaceuticals, Symbiomix Therapeutics, Mission Pharmacal Company, Bayer, Sanofi, Starpharma Holdings, Alfa Wassermann, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bacterial Vaginosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacterial Vaginosis Therapeutics.

The Bacterial Vaginosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacterial Vaginosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bacterial Vaginosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bacterial Vaginosis Therapeutics Market Report

Report Metric	Details
Report Name	Bacterial Vaginosis Therapeutics Market
Accounted market size in year	US$ 1108 million
Forecasted market size in 2031	US$ 1802 million
CAGR	7.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Medicine Surgery Other
Segment by Application	Hospitals Clinics Diagnostic Laboratories Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Merck, Novartis, Lupin Pharmaceuticals, Symbiomix Therapeutics, Mission Pharmacal Company, Bayer, Sanofi, Starpharma Holdings, Alfa Wassermann, AmVac, Evofem, Osel
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacterial Vaginosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bacterial Vaginosis Therapeutics Market growing?

Ans: The Bacterial Vaginosis Therapeutics Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the Bacterial Vaginosis Therapeutics Market size in 2031?

Ans: The Bacterial Vaginosis Therapeutics Market size in 2031 will be US$ 1802 million.

Who are the main players in the Bacterial Vaginosis Therapeutics Market report?

Ans: The main players in the Bacterial Vaginosis Therapeutics Market are Pfizer, Merck, Novartis, Lupin Pharmaceuticals, Symbiomix Therapeutics, Mission Pharmacal Company, Bayer, Sanofi, Starpharma Holdings, Alfa Wassermann, AmVac, Evofem, Osel

What are the Application segmentation covered in the Bacterial Vaginosis Therapeutics Market report?

Ans: The Applications covered in the Bacterial Vaginosis Therapeutics Market report are Hospitals, Clinics, Diagnostic Laboratories, Other

What are the Type segmentation covered in the Bacterial Vaginosis Therapeutics Market report?

Ans: The Types covered in the Bacterial Vaginosis Therapeutics Market report are Medicine, Surgery, Other

Recommended Reports

Female Health Disorders

Urinary Tract Disorders

Infection Treatments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bacterial Vaginosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Medicine

1.2.3 Surgery

1.2.4 Other

1.3 Market by Application

1.3.1 Global Bacterial Vaginosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Diagnostic Laboratories

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bacterial Vaginosis Therapeutics Market Perspective (2020-2031)

2.2 Global Bacterial Vaginosis Therapeutics Growth Trends by Region

2.2.1 Global Bacterial Vaginosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bacterial Vaginosis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Bacterial Vaginosis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Bacterial Vaginosis Therapeutics Market Dynamics

2.3.1 Bacterial Vaginosis Therapeutics Industry Trends

2.3.2 Bacterial Vaginosis Therapeutics Market Drivers

2.3.3 Bacterial Vaginosis Therapeutics Market Challenges

2.3.4 Bacterial Vaginosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bacterial Vaginosis Therapeutics Players by Revenue

3.1.1 Global Top Bacterial Vaginosis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Bacterial Vaginosis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Bacterial Vaginosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bacterial Vaginosis Therapeutics Revenue

3.4 Global Bacterial Vaginosis Therapeutics Market Concentration Ratio

3.4.1 Global Bacterial Vaginosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Therapeutics Revenue in 2024

3.5 Global Key Players of Bacterial Vaginosis Therapeutics Head office and Area Served

3.6 Global Key Players of Bacterial Vaginosis Therapeutics, Product and Application

3.7 Global Key Players of Bacterial Vaginosis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bacterial Vaginosis Therapeutics Breakdown Data by Type

4.1 Global Bacterial Vaginosis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Bacterial Vaginosis Therapeutics Breakdown Data by Application

5.1 Global Bacterial Vaginosis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bacterial Vaginosis Therapeutics Market Size (2020-2031)

6.2 North America Bacterial Vaginosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025)

6.4 North America Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bacterial Vaginosis Therapeutics Market Size (2020-2031)

7.2 Europe Bacterial Vaginosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Bacterial Vaginosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bacterial Vaginosis Therapeutics Market Size (2020-2031)

9.2 Latin America Bacterial Vaginosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Bacterial Vaginosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Bacterial Vaginosis Therapeutics Introduction

11.1.4 Pfizer Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Bacterial Vaginosis Therapeutics Introduction

11.2.4 Merck Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Bacterial Vaginosis Therapeutics Introduction

11.3.4 Novartis Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Lupin Pharmaceuticals

11.4.1 Lupin Pharmaceuticals Company Details

11.4.2 Lupin Pharmaceuticals Business Overview

11.4.3 Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Introduction

11.4.4 Lupin Pharmaceuticals Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.4.5 Lupin Pharmaceuticals Recent Development

11.5 Symbiomix Therapeutics

11.5.1 Symbiomix Therapeutics Company Details

11.5.2 Symbiomix Therapeutics Business Overview

11.5.3 Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Introduction

11.5.4 Symbiomix Therapeutics Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.5.5 Symbiomix Therapeutics Recent Development

11.6 Mission Pharmacal Company

11.6.1 Mission Pharmacal Company Company Details

11.6.2 Mission Pharmacal Company Business Overview

11.6.3 Mission Pharmacal Company Bacterial Vaginosis Therapeutics Introduction

11.6.4 Mission Pharmacal Company Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.6.5 Mission Pharmacal Company Recent Development

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Bacterial Vaginosis Therapeutics Introduction

11.7.4 Bayer Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.7.5 Bayer Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Bacterial Vaginosis Therapeutics Introduction

11.8.4 Sanofi Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.8.5 Sanofi Recent Development

11.9 Starpharma Holdings

11.9.1 Starpharma Holdings Company Details

11.9.2 Starpharma Holdings Business Overview

11.9.3 Starpharma Holdings Bacterial Vaginosis Therapeutics Introduction

11.9.4 Starpharma Holdings Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.9.5 Starpharma Holdings Recent Development

11.10 Alfa Wassermann

11.10.1 Alfa Wassermann Company Details

11.10.2 Alfa Wassermann Business Overview

11.10.3 Alfa Wassermann Bacterial Vaginosis Therapeutics Introduction

11.10.4 Alfa Wassermann Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.10.5 Alfa Wassermann Recent Development

11.11 AmVac

11.11.1 AmVac Company Details

11.11.2 AmVac Business Overview

11.11.3 AmVac Bacterial Vaginosis Therapeutics Introduction

11.11.4 AmVac Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.11.5 AmVac Recent Development

11.12 Evofem

11.12.1 Evofem Company Details

11.12.2 Evofem Business Overview

11.12.3 Evofem Bacterial Vaginosis Therapeutics Introduction

11.12.4 Evofem Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.12.5 Evofem Recent Development

11.13 Osel

11.13.1 Osel Company Details

11.13.2 Osel Business Overview

11.13.3 Osel Bacterial Vaginosis Therapeutics Introduction

11.13.4 Osel Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025)

11.13.5 Osel Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Merck

Novartis

Lupin Pharmaceuticals

Symbiomix Therapeutics

Mission Pharmacal Company

Bayer

Sanofi

Starpharma Holdings

Alfa Wassermann

AMVAC

Evofem Inc

Osel

List of Tables

Table 1. Global Bacterial Vaginosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Medicine

Table 3. Key Players of Surgery

Table 4. Key Players of Other

Table 5. Global Bacterial Vaginosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Bacterial Vaginosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Bacterial Vaginosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Bacterial Vaginosis Therapeutics Market Share by Region (2020-2025)

Table 9. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Bacterial Vaginosis Therapeutics Market Share by Region (2026-2031)

Table 11. Bacterial Vaginosis Therapeutics Market Trends

Table 12. Bacterial Vaginosis Therapeutics Market Drivers

Table 13. Bacterial Vaginosis Therapeutics Market Challenges

Table 14. Bacterial Vaginosis Therapeutics Market Restraints

Table 15. Global Bacterial Vaginosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Bacterial Vaginosis Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Bacterial Vaginosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaginosis Therapeutics as of 2024)

Table 18. Ranking of Global Top Bacterial Vaginosis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Bacterial Vaginosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Bacterial Vaginosis Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Bacterial Vaginosis Therapeutics, Product and Application

Table 22. Global Key Players of Bacterial Vaginosis Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Bacterial Vaginosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Bacterial Vaginosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Bacterial Vaginosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Bacterial Vaginosis Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Bacterial Vaginosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Bacterial Vaginosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Bacterial Vaginosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Bacterial Vaginosis Therapeutics Product

Table 50. Pfizer Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Merck Company Details

Table 53. Merck Business Overview

Table 54. Merck Bacterial Vaginosis Therapeutics Product

Table 55. Merck Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Novartis Company Details

Table 58. Novartis Business Overview

Table 59. Novartis Bacterial Vaginosis Therapeutics Product

Table 60. Novartis Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Lupin Pharmaceuticals Company Details

Table 63. Lupin Pharmaceuticals Business Overview

Table 64. Lupin Pharmaceuticals Bacterial Vaginosis Therapeutics Product

Table 65. Lupin Pharmaceuticals Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Lupin Pharmaceuticals Recent Development

Table 67. Symbiomix Therapeutics Company Details

Table 68. Symbiomix Therapeutics Business Overview

Table 69. Symbiomix Therapeutics Bacterial Vaginosis Therapeutics Product

Table 70. Symbiomix Therapeutics Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Symbiomix Therapeutics Recent Development

Table 72. Mission Pharmacal Company Company Details

Table 73. Mission Pharmacal Company Business Overview

Table 74. Mission Pharmacal Company Bacterial Vaginosis Therapeutics Product

Table 75. Mission Pharmacal Company Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Mission Pharmacal Company Recent Development

Table 77. Bayer Company Details

Table 78. Bayer Business Overview

Table 79. Bayer Bacterial Vaginosis Therapeutics Product

Table 80. Bayer Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Bayer Recent Development

Table 82. Sanofi Company Details

Table 83. Sanofi Business Overview

Table 84. Sanofi Bacterial Vaginosis Therapeutics Product

Table 85. Sanofi Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Sanofi Recent Development

Table 87. Starpharma Holdings Company Details

Table 88. Starpharma Holdings Business Overview

Table 89. Starpharma Holdings Bacterial Vaginosis Therapeutics Product

Table 90. Starpharma Holdings Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Starpharma Holdings Recent Development

Table 92. Alfa Wassermann Company Details

Table 93. Alfa Wassermann Business Overview

Table 94. Alfa Wassermann Bacterial Vaginosis Therapeutics Product

Table 95. Alfa Wassermann Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Alfa Wassermann Recent Development

Table 97. AmVac Company Details

Table 98. AmVac Business Overview

Table 99. AmVac Bacterial Vaginosis Therapeutics Product

Table 100. AmVac Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 101. AmVac Recent Development

Table 102. Evofem Company Details

Table 103. Evofem Business Overview

Table 104. Evofem Bacterial Vaginosis Therapeutics Product

Table 105. Evofem Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 106. Evofem Recent Development

Table 107. Osel Company Details

Table 108. Osel Business Overview

Table 109. Osel Bacterial Vaginosis Therapeutics Product

Table 110. Osel Revenue in Bacterial Vaginosis Therapeutics Business (2020-2025) & (US$ Million)

Table 111. Osel Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Bacterial Vaginosis Therapeutics Picture

Figure 2. Global Bacterial Vaginosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bacterial Vaginosis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Medicine Features

Figure 5. Surgery Features

Figure 6. Other Features

Figure 7. Global Bacterial Vaginosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Bacterial Vaginosis Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Diagnostic Laboratories Case Studies

Figure 12. Other Case Studies

Figure 13. Bacterial Vaginosis Therapeutics Report Years Considered

Figure 14. Global Bacterial Vaginosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Bacterial Vaginosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Bacterial Vaginosis Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Bacterial Vaginosis Therapeutics Market Share by Players in 2024

Figure 18. Global Top Bacterial Vaginosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacterial Vaginosis Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Therapeutics Revenue in 2024

Figure 20. North America Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Bacterial Vaginosis Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Bacterial Vaginosis Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Bacterial Vaginosis Therapeutics Market Share by Region (2020-2031)

Figure 34. China Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Bacterial Vaginosis Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Bacterial Vaginosis Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Bacterial Vaginosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Pfizer Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 52. Lupin Pharmaceuticals Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 53. Symbiomix Therapeutics Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 54. Mission Pharmacal Company Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 56. Sanofi Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 57. Starpharma Holdings Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 58. Alfa Wassermann Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 59. AmVac Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 60. Evofem Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 61. Osel Revenue Growth Rate in Bacterial Vaginosis Therapeutics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Bacterial Vaginosis Drug Market Insights Forecast to 2030

Global Vaginosis Drug Market Insights Forecast to 2030

Bacterial Vaginosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bacterial Vaginosis Rx Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bacterial Vaginosis OTC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bacterial Vaginosis Detector Market Research Report 2024

Global Bacterial Vaginosis Test Kit Market Research Report 2024

Global Vaginosis Rapid Testing Market Research Report 2024

Global Vaginitis Therapeutics Market Insights Forecast to 2030

Global Bacterial Disease Diagnostics Market Insights Forecast to 2030

Postmenopausal Vaginal Atrophy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Postmenopausal Vaginal Atrophy PVA Therapeutics Market Insights Forecast to 2030

Bacterial Vaginosis BV Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antimicrobial Therapeutics Market Insights Forecast to 2030

Global Gram Negative Bacterial Infection Therapeutics Market Research Report 2024

Global Necrotizing Fasciitis Drug Market Insights Forecast to 2030

Global Oral Medicine for Vaginitis Market Research Report 2024

Global Sexually Transmitted Disease Therapeutics Market Insights Forecast to 2030

Global Bronchiectasis Drugs Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions